Failure to commercialize enriched isotopes
The company has not yet generated revenue from enriched isotopes, so the core business depends on successful development and scale-up.
- Scope
- Specialist isotopes and related services
- Materiality
- high
ASP Isotopes Inc.
ASP Isotopes Inc. is a development-stage advanced materials company built around proprietary isotope-separation technologies, including Aerodynamic Separation Process (ASP) and Quantum Enrichment (QE). The company is focused on producing high-value, low-volume isotopes for specialized end markets such as pharmaceuticals, agrochemicals, nuclear medical imaging, and semiconductors. It also has a separate nuclear fuels business through Quantum Leap Energy (QLE), which is being developed around HALEU and Lithium-6 for advanced nuclear applications. In 2025, the company expanded further into construction services through its Skyline acquisition, adding a third operating segment alongside specialist isotopes and nuclear fuels.
−243,2 %
14,3 %
−670,2 %
+475,5 %
12.23
12.20
| % | |
|---|---|
| Specialist isotopes and related services | 35% Development and commercialization of high-value, low-volume isotopes and related services for medical, industrial, and semiconductor uses. |
| Nuclear fuels | 5% Research, development, and commercialization of advanced nuclear fuel products such as HALEU and Lithium-6 through QLE. |
| Nuclear medical doses | 20% Production and sale of PET scanning doses used in nuclear medical imaging, primarily through PET Labs in South Africa. |
| Construction services | 40% Civil engineering and subcontracted construction work, including road and drainage projects in Hong Kong via Skyline. |
ASP Isotopes serves highly specialized customers that need isotopes with precise enrichment, purity, and supply...
- Specialty isotope end usersprimary
Buy enriched isotopes such as C-14, Mo-100, Si-28, and Yb-176 for pharmaceutical, agrochemical, semiconductor, and research applications.
- Advanced nuclear fuel developerssecondary
Seek HALEU and Lithium-6 products and related development capabilities for next-generation nuclear fuel supply chains.
- PET imaging and nuclear medicine customerssecondary
Purchase nuclear medical doses used in PET scanning, supporting diagnostic imaging workflows in South Africa.
- Public infrastructure and civil engineering clientssecondary
Buy road, drainage, and related civil engineering services in Hong Kong through Skyline/Kin Chiu Engineering.
ASP Isotopes operates through subsidiaries in the United Kingdom, South Africa, Iceland, the Cayman Islands, and...
- •United States is the parent company domicile and capital markets base
- •United Kingdom houses the technology owner and part of the nuclear fuels structure
- •South Africa is important for PET dose production and isotope-related operations
- •Hong Kong contributes construction revenue through Skyline/Kin Chiu Engineering
- •Cayman Islands, Guernsey, and Iceland are part of the subsidiary structure
- •Cross-border operations increase regulatory and execution complexity
ASP Isotopes is trying to commercialize proprietary isotope-enrichment technologies while still in a development-stage...
01
Commercialize specialist isotopesshort-term
The company needs to convert R&D into repeatable production and sales to create a durable revenue base.
02
Build the QLE nuclear fuels platformmedium-term
HALEU and Lithium-6 could become strategically important products in advanced nuclear supply chains.
03
Separate and finance businesses independentlymedium-term
A spin-out could align capital allocation with distinct regulatory and commercial profiles across business lines.
04
Grow operating revenue through acquisitionsshort-term
Adding revenue-generating businesses can reduce dependence on pre-commercial isotope development.
ASP Isotopes faces substantial execution risk because most of its core isotope businesses are still in development and...
Regulatory and licensing delays in nuclear fuels
HALEU and Lithium-6 production is subject to a more complex regulatory landscape than medical isotopes.
- Scope
- Nuclear fuels
- Materiality
- high
Financing and dilution risk
Operations have been funded mainly through equity and convertible notes, and future development will likely require additional capital.
- Scope
- Company-wide
- Materiality
- high
Fair value volatility on convertible notes
Changes in the fair value of convertible notes can materially affect reported earnings and obscure operating performance.
- Scope
- Company-wide
- Materiality
- medium
Construction execution and subcontracting risk
The Skyline business depends on project delivery, subcontractor performance, and cost control on civil engineering contracts.
- Scope
- Construction services
- Materiality
- medium
Trade policy, inflation, and foreign exchange
The company operates across multiple jurisdictions and imports/exports specialized materials and services.
- Scope
- South Africa, United Kingdom, Hong Kong
- Materiality
- medium
Revenue recognition by segment
Revenue timing and gross margin
Fair value of convertible notes payable
Net loss volatility
Share liability and equity-linked awards
Other income/expense
R&D expense recognition
Operating loss
Lease accounting
EBITDA and lease obligations
APA Corp
APA · Crude Petroleum & Natural Gas
APA Corp is an independent energy holding company whose operating subsidiaries explore for, develop, and produce crude oil, natural gas, and natural gas liquids.
Atlas Lithium Corp
ATLX · Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Atlas Lithium Corp is a U.S.-listed mineral exploration and development company focused on advancing a hard-rock lithium project in Minas Gerais, Brazil,…
Actinium Pharmaceuticals, Inc.
ATNM · Pharmaceutical Preparations
VIVOS INC
RDGL · Surgical & Medical Instruments & Apparatus
Oklo Inc.
OKLO · Electric Services
ASPAC III Acquisition Corp.
ASPC · Blank Checks
: 11/08/2026